Document:

EX-10.2

 Exhibit 10.2 

AKCEA THERAPEUTICS, INC. 

September 19, 2019 
 Damien McDevitt 

Akcea Therapeutics, Inc. 
 22 Boston Wharf Road, 9th Floor 
 Boston, MA 02210 
  

	Re:	 Severance and Equity Award Vesting Acceleration  

Dear Damien: 
 We are pleased to inform you that
the Compensation Committee of the Board of Directors of Akcea Therapeutics, Inc. (the “Company”) has approved severance and vesting acceleration terms for you, which are described in this letter agreement (the
“Agreement”). This Agreement will supersede and replace any prior agreements providing for severance benefits by and between you and the Company. 

The vesting acceleration described in Section 2 below will apply to the following equity awards (collectively, the “Equity
Awards”): 
  

	 	•	 	 your outstanding compensatory equity awards granted to you on or prior to the date hereof under the 2015 Equity
Incentive Plan, as amended (the “2015 Plan”) that are subject to a time-based vesting schedule; and 

  

	 	•	 	 unless otherwise expressly provided by the Company at the time of grant, any future compensatory equity awards
covering Company common stock, including awards of stock options, restricted stock, restricted stock units or other types of equity awards, as applicable, that the Company may grant to you in the future and that are subject to a time-based vesting
schedule. 

 Capitalized terms used in this Agreement and not defined herein will have the meanings set forth in the
applicable equity incentive plan. This Agreement amends the terms of the Equity Awards that have previously been granted to you and are currently outstanding. For purposes of clarity, any compensatory equity awards that are subject to
performance-based vesting will not be “Equity Awards” hereunder and will only vest, if at all, in accordance with the terms of the applicable Plan and award agreement. 

1. Severance. If you experience a Qualifying Termination (as defined below), then, provided you timely comply with the conditions
described in Section 3: 
 (a) the Company will pay you an amount equal to your then current base salary (disregarding for this purpose,
any reduction of your base salary that results in a termination of your employment for Good Reason) payable during the applicable Severance Period (less payroll deductions and withholdings), payable in a single lump- sum within 60 days after the
date of your Qualifying Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, such payment will be made in the second calendar year;

 (b) if you timely elect to continue coverage under the Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended (“COBRA”), the Company will pay your COBRA premiums, and any applicable Company COBRA premiums, necessary to continue your then-current coverage until the earliest of (A) the end of
the applicable Severance Period, (B) the expiration of your eligibility for the continuation coverage under COBRA and (C) the date you become eligible to enroll in a health insurance plan offered by another employer or entity. You agree to
immediately notify the Company in writing of any such enrollment or eligibility for enrollment and the Company’s obligation to pay any COBRA premiums will immediately cease. Notwithstanding the foregoing, if the Company determines, in its sole
discretion, that it cannot provide the foregoing benefit without potentially incurring financial costs or penalties under applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company will in lieu
thereof provide you with a taxable monthly amount (which amount will be based on the premium for the first month of COBRA coverage hereunder), which payments will be made regardless of whether you elect COBRA continuation coverage. If the Company
elects to make such payments in lieu of paying such COBRA premiums, the payments will end on the earliest of the dates specified above; and 

(c) if such Qualifying Termination occurs within nine months of the date hereof and following such termination you do not return to employment
with Ionis Pharmaceuticals, Inc., then the lump-sum payment described in (a) above will also include an amount equal to your target annual cash performance bonus for the year of termination multiplied by
a fraction, the denominator of which will be 12 and the numerator of which will be the number of months in the applicable Severance Period. 

(d) if such Qualifying Termination occurs during the Change in Control Period, then the lump-sum
payment described in (a) above will also include an amount equal to your target annual cash performance bonus for the year of termination multiplied by a fraction, the denominator of which will be 12 and the numerator of which will be the
number of months in the applicable Severance Period; provided, however, that if such Qualifying Termination occurs after June 30 of any year, the included amount will be equal to your full target annual cash performance bonus for the year of
termination. 
 2. Equity Award Vesting Acceleration. 

(a) If you experience a Qualifying Termination prior to a Change in Control, then, provided you timely comply with the conditions described in
Section 3, you shall become fully vested in any and all Equity Awards that would have vested during the 12 month period following the date of your Qualifying Termination. 

  
 2 

 (b) If, in connection with a Change in Control, (x) an Equity Award is assumed or
continued by the successor or acquiror entity in such Change in Control or such Equity Award is substituted for a similar award of the successor or acquiror entity, and (y) you experience a Qualifying Termination within the Change in Control
Period, then, provided you timely comply with the conditions described in Section 3 below, you will become vested, effective as of the date that is 60 days following the date of such Qualifying Termination (or, if later, the effective date of
such Change in Control) with respect to 100 percent of any then unvested portion of any applicable Equity Award. 
 (c) If, in
connection with a Change in Control, an Equity Award will terminate and will not be so assumed or continued by the successor or acquiror entity in such Change in Control or substituted for a similar award of the successor or acquiror entity, then,
you will become vested, with respect to 100 percent of any then unvested portion of any applicable Equity Award, effective immediately prior to, but subject to the consummation of such Change in Control. 

3. Conditions to Receipt of Severance and Equity Award Vesting Acceleration. In order to receive the severance and Equity Award vesting
acceleration described in Sections 1 and 2(a), above, you must sign a separation agreement containing, among other provisions, a general release of claims in favor of the Company and related persons and entities, confidentiality, return of property
and non-disparagement, in each case in a form and manner satisfactory to the Company (the “Separation Agreement and Release”) and the Separation Agreement and Release must become
irrevocable, all within 60 days after your Qualifying Termination. In order to effect the provisions of this Section 3, any termination or forfeiture of any unvested Equity Awards eligible for acceleration of vesting pursuant to
Section 2(a) above that otherwise would have occurred on or within 60 days after your Qualifying Termination will be delayed until the 60th day after the date of your Qualifying Termination (but, in the case of any stock option, not later than
the expiration date of such stock option specified in the applicable option agreement) and will only occur to the extent such equity awards do not vest pursuant to Section 2(a) above and, for purposes of clarity, no additional vesting of any
Equity Award will occur during such 60 day period. 
 4. Restrictive Covenants. In consideration of the benefits under this Agreement,
you will sign Company’s Employee Confidential Information, Inventions Assignment, Non-Competition and Non-Solicitation Agreement. 

5. Certain Definitions. For purposes of this Agreement, the following terms have the following meanings: 

(a) “Cause” means: (i) any material breach of this Agreement or any other written agreement between you and the
Company, if such breach causes material harm to the Company or reasonably threatens to cause such harm; (ii) any material failure to comply with the Company’s written policies or rules, as they may be in effect from time to time during
your employment, if such failure causes material harm to the Company, and to the extent it is curable by you, is not cured within 30 days after written notice thereof is given to you by the Company; (iii) commission, conviction of, or a plea of
“guilty” or “no contest” to, a felony under the laws of the United States or any State; (iv) any willful, intentional or grossly negligent act having the effect of materially injuring (whether financially or otherwise) the
business or reputation of the Company, 

  
 3 

 
which to the extent it is curable by you, is not cured within 30 days after written notice thereof is given to you by the Company; or (v) willful misconduct with respect to any of your
material duties or obligations under this Agreement, which, to the extent it is curable is not cured within 30 days after written notice thereof is given to you by the Company. 

(b) “Change in Control” means the sale of all or substantially all the assets of the Company; any merger,
consolidation or acquisition of the Company with, by or into another corporation, entity or person; or any change in the ownership of more than 50% of the voting capital stock of the Company in one or more related transactions, provided, none
of the following events will be a Change in Control: (1) acquisitions of capital stock directly from the Company for cash, whether in a public or private offering, (2) distributions of capital stock by the Company’s stockholders,
(3) acquisitions of capital stock by or from any employee benefit plan or related trust, or (4) a merger the sole purpose of which is to change the Company’s name and/or state of incorporation. 

(c) “Change in Control Period” means the period commencing on the effective date of a Change of Control and ending 12
months following such date. 
 (d) “Good Reason” means the occurrence of any of the following events without your
consent; provided, that any resignation by you due to any of the following conditions will only be deemed for Good Reason if: (i) you give the Company written notice of the intent to terminate for Good Reason within 90 days following the
first occurrence of the condition(s) that you believe constitutes Good Reason, which notice will describe such condition(s); (ii) the Company fails to remedy, if remediable, such condition(s) within 30 days following receipt of your written notice
(the “Cure Period”) of such condition(s) from you; and (iii) you actually resign your employment within the first 15 days after expiration of the Cure Period: (a) a material reduction by the Company of your base
salary as in effect immediately prior to the reduction; (b) a material reduction by the Company of your annual bonus target as in effect immediately prior to the reduction, provided a compensation plan change that affects similarly all
employees at similar levels will not constitute Good Reason; (c) a material reduction in your authority, duties or responsibilities, provided a change in job title or reporting relationship without a reduction in your base salary or
annual bonus target will not constitute Good Reason; or (d) relocation of the offices at which you are required to work to a location that would increase your one-way commute by more than 40 miles. Your
death or disability will not constitute a without Cause termination or Good Reason resignation under this Agreement. 
 (e)
“Qualifying Termination” means a termination of your Continuous Service (as defined in the 2015 Plan) either (x) by the Company without Cause or (y) by you with Good Reason. Termination of Continuous Service due to
your death or Disability (as defined in the 2015 Plan) will not constitute a Qualifying Termination. For clarity, if you terminate your employment without Good Reason, and the Company unilaterally accelerates your date of termination in connection
therewith, such acceleration will not result in a termination by the Company without Cause or a Qualifying Termination hereunder. Notwithstanding the foregoing, solely in the case where the Board of Directors or its Compensation Committee both
(a) determines not to 

  
 4 

 
employ you as the Company’s permanent Chief Executive Officer within nine months of your employment start date, and (b) requests that you complete a transition period of employment of
up to six months (but not longer than 45 days after a permanent Chief Executive Officer is hired or appointed) (the “Transition Period”) following such determination, then you must first complete such Transition Period of
employment in order for your termination to constitute a “Qualifying Termination”. 
 (f) “Severance
Period” means 15 months, provided that the Severance Period will instead be 21 months to the extent that a Qualifying Termination occurs during the Change in Control period. 

6. Section 409A. The payments and benefits under this Agreement are intended to qualify for an exemption from application of
Section 409A of the Code (“Section 409A”) or comply with its requirements to the extent necessary to avoid adverse personal tax consequences under Section 409A, and any ambiguities
herein will be interpreted accordingly. To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under Section 409A, and to the
extent that such payment or benefit is payable upon the termination of your employment, then such payments or benefits will be payable only upon your “separation from service.” The determination of whether and when a separation from
service has occurred will be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h). Notwithstanding anything in this Agreement to the contrary, if at the time of your separation from service, the Company
determines that you are a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this Agreement on account of your separation from
service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment will not
be payable and such benefit will not be provided until the date that is the earlier of (A) six months and one day after your separation from service, (B) your death, or (C) such earlier date as permitted under Section 409A
without imposition of adverse taxation. If any such delayed cash payment is otherwise payable on an installment basis, the first payment will include a catch-up payment covering amounts that would otherwise
have been paid during the six-month period but for the application of this provision, and the balance of the installments will be payable in accordance with their original schedule. The Company makes no
representation or warranty and will have no liability to you or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A but do not satisfy an exemption from, or the
conditions of, Section 409A. 
 7. Parachute Payments. If any payment or benefit you would receive from the Company or otherwise
in connection with a Change in Control or other similar transaction (a “280G Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this
sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then any such 280G Payment (a “Payment”) will be equal to the Reduced Amount. The “Reduced
Amount” will be either (x) the largest portion of the Payment that would result in no portion of the 

  
 5 

 
Payment (after reduction) being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount (i.e., the amount determined by clause
(x) or by clause (y)), after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in your receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence
and the Reduced Amount is determined pursuant to clause (x) of the preceding sentence, the reduction will occur in the manner (the “Reduction Method”) that results in the greatest economic benefit for you. If more than
one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the “Pro Rata Reduction Method”). 

Notwithstanding the foregoing, if the Reduction Method or the Pro Rata Reduction Method would result in any portion of the Payment being
subject to taxes pursuant to Section 409A of the Code that would not otherwise be subject to taxes pursuant to Section 409A of the Code, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, will be modified
so as to avoid the imposition of taxes pursuant to Section 409A of the Code as follows: (A) as a first priority, the modification will preserve to the greatest extent possible, the greatest economic benefit for you as determined on an after-tax basis; (B) as a second priority, Payments that are contingent on future events (e.g., being terminated without cause), will be reduced (or eliminated) before Payments that are not contingent on future
events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning of Section 409A of the Code will be reduced (or eliminated) before Payments that are not deferred compensation within the meaning
of Section 409A of the Code. 
 Unless you and the Company agree on an alternative accounting firm, the accounting firm engaged by the
Company for general tax compliance purposes as of the day prior to the effective date of the change of control transaction triggering the Payment will perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as
accountant or auditor for the individual, entity or group effecting the change of control transaction, the Company will appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company will bear all expenses
with respect to the determinations by such accounting firm required to be made hereunder. The Company will use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder to provide its calculations,
together with detailed supporting documentation, to you and the Company within 15 calendar days after the date on which your right to a 280G Payment becomes reasonably likely to occur (if requested at that time by you or the Company) or such other
time as requested by you or the Company. 
 If you receive a Payment for which the Reduced Amount was determined pursuant to clause
(x) of the first paragraph of this Section and the Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, you will promptly return to the Company a sufficient amount of the Payment (after
reduction pursuant to clause (x) of the first paragraph of this Section so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y) in
the first paragraph of this Section, you will have no obligation to return any portion of the Payment pursuant to the preceding sentence. 

  
 6 

 8. Miscellaneous. This Agreement sets forth the entire understanding between you and
the Company with respect to the subject matter hereto and supersedes all prior oral and written agreements, promises and/or representations on that subject. This Agreement is not an agreement of employment and will not confer upon you any right to
be retained by or in the employ of the Company and will not interfere in any way with the right of the Company to terminate your employment or service arrangement at any time or for any reason. This Agreement will be binding upon any surviving
entity resulting from a Change in Control of the Company and upon any other person who is a successor by merger, acquisition, consolidation or otherwise to the business formerly carried on by the Company without regard to whether or not such person
or entity actively assumes the obligations hereunder. The terms of this Agreement, and any action arising hereunder, will be governed by and construed in accordance with the domestic laws of the Commonwealth of Massachusetts without giving effect to
any choice of law or conflict of law provision or rule (whether of the Commonwealth of Massachusetts or other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Massachusetts and you hereby
expressly consent to the personal jurisdiction and venue of the state and federal courts located in the Commonwealth of Massachusetts for any lawsuit filed there against you by Company arising from or related to this Agreement. 

  
 7 

 Except as provided herein, all terms and conditions of your Equity Awards and any other
written agreement between you and the Company remain in full force and effect and are not amended by this Agreement. 
 Please countersign
below to acknowledge your receipt of this Agreement and your agreement to the terms described herein. 
 With best regards, 

Akcea Therapeutics, Inc. 
  

	
	 /s/ Sandford D. Smith

	Sandford D. Smith
	Compensation Committee Chairman

  

	
	Acknowledged and agreed:
	
	 /s/ Damien McDevitt

	Damien McDevitt, Ph.D.

  
 8EX-10.1

 EXHIBIT 10.1 

Execution Version 

LIMITED WAIVER AND FIRST AMENDMENT TO 

CREDIT AGREEMENT 
 This
LIMITED WAIVER AND FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) dated as of September 16, 2019, is by and among Roan Resources, Inc., Delaware corporation (the “Borrower”); Cortland Capital Market
Services LLC, as administrative agent for the Lenders (in such capacity, together with its successors, the “Administrative Agent”) and the Lenders signatory hereto. 

Recitals 
 WHEREAS,
Borrower, Administrative Agent and the Lenders are parties to the Credit Agreement dated as of June 27, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), pursuant to
which the Lenders have made certain credit available to and on behalf of Borrower. 
 WHEREAS, Borrower has requested and the Lenders have
agreed to amend the Credit Agreement in certain respects as hereinafter provided. 
 WHEREAS, Borrower has advised the Administrative Agent
that it delivered evidence of recording of all Mortgages pursuant to Section 9.16(a) of the Credit Agreement after the post-closing deadline (such violation, the “Specified Violation”). 

NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained, for good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 Section 1. Defined Terms. Each
capitalized term which is defined in the Credit Agreement, but which is not defined in this Amendment, shall have the meaning ascribed such term in the Credit Agreement. Unless otherwise indicated, all references to sections and articles in this
Amendment refer to sections and articles of the Credit Agreement. 
 Section 2. Limited Waiver. In reliance on the
representations, warranties, covenants and agreements contained in this Amendment, and subject to the satisfaction of the conditions precedent set forth in Section 4 hereof, the Lenders hereby waive any Default or Event of
Default arising solely as a result of the Specified Violation. 
 The limited waiver granted in this Section 2 is a one-time waiver and limited solely to the Specified Violation and nothing contained in this Section 2 shall be deemed a consent to, or waiver of, any other action or inaction of any Credit
Party which constitutes (or would constitute) a violation of any provision of the Credit Agreement or any other Credit Document. Neither the Lenders nor Administrative Agent shall be obligated to grant any future waivers, consents or amendments with
respect to any other provision of the Credit Agreement or any other Credit Document and such limited waiver shall not constitute a course of dealing among the parties. 

 Section 3. Amendments to Credit Agreement. 

(a) Section 1.1 of the Credit Agreement is hereby amended by adding the following defined terms in proper alphabetical order: 

“Curlin Asset Value” shall mean with respect to any wellbore (or potential wellbore), an amount equal to
(x) the number of acres associated with the applicable Curlin Assets for the section upon which such wellbore (or potential wellbore) is located times (y) the value per acre in such section based on the nri of Roan Resources Inc. (as
approved by the Oklahoma Corporation Commission) divided by (z) the total number of reasonably assumed potential wells per such section (which shall be four per section unless approved by the Administrative Agent (acting at the direction of the
Required Lenders)). 
 “Disposed Wellbores” shall have the meaning provided in
Section 10.4(p). 
 “Qualified Wellbore Proposal” shall have the meaning provided
in Section 10.4(p). 
 (b) Section 5.2(a)(i) of the Credit Agreement is hereby amended and restated in its entirety
to the following: 
 “(i) any Disposition by the Credit Parties or any of their Subsidiaries pursuant to
Section 10.4; provided, that no mandatory prepayment shall be required with the proceeds of a Disposition made in reliance on Section 10.4(p) so long as the proceeds of such sale are held in a
segregated deposit account that is subject to a Control Agreement that does not permit withdrawals from such account (except with the consent of the Administrative Agent acting at the direction of the Required Lenders (other than withdrawals for the
payment of account fees or similar expenses related to the maintenance of such deposit account)) or” 
 (c) Section 10.4 of the Credit
Agreement is hereby amended by deleting the “and” at the end of clause (n) thereof, replacing the “.” with “; and” at the end of clause (o) thereof and adding the following clause (p): 

“(p) Dispositions of wellbores or potential wellbores (limited, for the avoidance of doubt, to the specific wellbores and
not including any other portion of the common resource) that comprise less than all or substantially all of the Curlin Assets (with respect to any such Disposition, the “Disposed Wellbores”) to OpCo or any of the OpCo Subsidiaries
so long as (i) the proceeds received by the Borrower from such Disposition are 100% in cash, (ii) the amount received is greater than or equal to the aggregate Curlin Asset Value of the Disposed Wellbores at the time of such Disposition,
(iii) such Disposition (A) is consummated within thirty (30) days of the receipt of a wellbore proposal by the Borrower from a third-party that is not an Affiliate of OpCo or the Borrower (a “Qualified Wellbore
Proposal”) and (B) is limited to wellbores subject to such Qualified Wellbore Proposal, (iv) the Borrower delivers notice to the Administrative Agent (which shall provide such notice to the Lenders as soon as practicable) at least
10 Business 

  
 2 

 
Days in advance of the proposed Disposition which notice shall include (A) a certification of an Authorized Officer of the Borrower (x) that a true and correct copy of the applicable
Qualified Wellbore Proposal is attached to such notice and (y) of the aggregate Curlin Asset Value attributable to the Disposed Wellbores, (B) drafts of the definitive legal documentation for such Disposition and (C) legal
descriptions of the Disposed Wellbores, (v) such Disposed Wellbores are to be operated by a Person that is not an Affiliate of OpCo or the Borrower. For the avoidance of doubt, the Administrative Agent shall only be required to deliver the
notice and the other documentation received by the Administrative Agent to the Lenders, and the Administrative Agent shall not be required to determine the completeness of such documentation or the accuracy of the calculations contained in such
documents. 
 (d) Section 10.4(i) of the Credit Agreement is hereby amended and restated in its entirety to the following: 

“(i) the Disposition of all or substantially all of the Curlin Assets subject to (A) there being no Default or Event
of Default after giving effect to such Disposition and (B) Net Cash Proceeds received by the Borrower in respect of such Disposition being greater than $50,000,000;” 

(e) Section 10.12(k) of the Credit Agreement is hereby amended and restated in its entirety to the following: 

“(k) the transactions consummated pursuant to Section 10.4(p) hereunder; and” 

Section 4. Conditions Precedent 

Section 4.1. The Administrative Agent shall have received from the Lenders counterparts (in such number as may be requested by
Administrative Agent) of this Amendment signed on behalf of such Persons. 
 Section 4.2. The Administrative Agent shall have received
a certificate of an Authorized Officer, dated as of the Amendment Effective Date, certifying that the representations and warranties set forth in Section 5.3 of this Amendment are true and correct in all material respects.

 Section 4.3. The Administrative Agent and the Lenders shall have been reimbursed for all reasonable
out-of-pocket expenses required to be reimbursed or paid by the Borrower under the Credit Agreement (including, without limitation, the reasonable and documented fees
and expenses of counsel to the Administrative Agent, Holland & Knight LLP and counsel to each of the Lenders, including Simpson Thacher & Bartlett LLP, Akin Gump Strauss Hauer & Feld LLP and Thompson & Knight
LLP). 
 Administrative Agent is hereby authorized and directed to declare this Amendment to be effective (and the “Amendment
Effective Date” shall occur) when it has received documents confirming or certifying, to the satisfaction of Administrative Agent, compliance with the conditions set forth in this Section 4 or the waiver of such
conditions as permitted in Section 13.1 of the Credit Agreement. Such declaration shall be final, conclusive and binding upon all parties to the Credit Agreement for all purposes. 

  
 3 

 Section 5. Miscellaneous. 

Section 5.1. Confirmation. The provisions of the Credit Agreement, as amended and modified by this Amendment, shall remain in full
force and effect following the Amendment Effective Date. 
 Section 5.2. Ratification and Affirmation. The Borrower and each
Guarantor hereby (a) acknowledges the terms of this Amendment; (b) ratifies and affirms its obligations under, and acknowledges its continued liability under, each Credit Document to which it is a party and agrees that each Credit Document
to which it is a party remains in full force and effect as expressly amended hereby; and (c) agrees that from and after the Amendment Effective Date each reference to the Credit Agreement in the Guarantee and the other Credit Documents shall be
deemed to be a reference to the Credit Agreement, as amended and modified by this Amendment. 
 Section 5.3. Representations and
Warranties. The Borrower hereby represents and warrants to the Lenders that, immediately prior to and after giving effect to this Amendment, (a) no Default or Event of Default has occurred and is continuing; (b) no event or events have
occurred which individually or in the aggregate could reasonably be expected to have a Material Adverse Effect; and (c) all representations and warranties made by any Credit Party contained in the Credit Agreement or in the other Credit
Documents are true and correct in all material respects (unless such representation or warranty contains a materiality qualifier in which case such representation or warranty shall be true and correct in all respects) with the same effect as though
such representations and warranties had been made on and as of the Amendment Effective Date (except where such representations and warranties expressly relate to an earlier date, in which case such representations and warranties shall have been true
and correct in all material respects (unless such representation or warranty contains a materiality qualifier in which case such representation or warranty shall be true and correct in all respects) as of such earlier date). 

Section 5.4. Credit Document. This Amendment is a Credit Document and shall be construed, administered and applied in accordance
with the terms and provisions of the Credit Agreement. On and after the effectiveness of this Agreement, each reference in each Credit Document to the “Credit Agreement”, “thereunder”, “thereof” or words of like import
referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended or otherwise modified by this Amendment. 

Section 5.5. Counterparts. This Amendment may be executed by one or more of the parties hereto in any number of separate
counterparts, and all of such counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed counterpart of a signature page of this Amendment by telecopy, facsimile or other similar electronic means
shall be effective as delivery of a manually executed counterpart of this Amendment. 

  
 4 

 Section 5.6. No Oral Agreement. This Amendment, the Credit Agreement and the
other Credit Documents executed in connection herewith and therewith represent the final agreement between the parties and may not be contradicted by evidence of prior, contemporaneous, or unwritten oral agreements of the parties. There are no
subsequent oral agreements between the parties. 
 Section 5.7. No Waiver. The execution, delivery and effectiveness of this
Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of the Administrative Agent or any Lender under any of the Credit Documents, nor constitute a waiver of any provision of any of the Credit
Documents. 
 Section 5.8. GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE
STATE OF NEW YORK. 
 Section 5.9. Payment of Expenses. In accordance with Section 13.5 of the Credit
Agreement, Borrower agrees to pay or reimburse Administrative Agent for all of its reasonable out-of-pocket costs and reasonable expenses incurred in connection with
this Amendment, any other documents prepared in connection herewith and the transactions contemplated hereby, including, without limitation, the reasonable fees and disbursements of counsel to Administrative Agent. 

Section 5.10. Severability. Any provision of this Amendment which is prohibited or unenforceable in any jurisdiction shall, as to
such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction. 
 Section 5.11. Successors and Assigns. This Amendment shall be binding
upon and inure to the benefit of the parties hereto and their respective successors and assigns. 
 Section 5.12. WAIVER OF JURY
TRIAL. THE BORROWER, THE GUARANTORS, THE ADMINISTRATIVE AGENT, EACH LETTER OF CREDIT ISSUER AND EACH LENDER HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AMENDMENT OR ANY OTHER
CREDIT DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN. 
 (Signature Pages Follow) 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed
effective as of the Amendment Effective Date. 
  

			
	ROAN RESOURCES, INC., as Borrower
		
	By:	 	 /s/ David Edwards

		 	Name: David Edwards
		 	Title:   Chief Financial Officer

  
 Signature Page to Limited
Waiver and First Amendment to Credit Agreement 

 
			
	CORTLAND CAPITAL MARKET SERVICES LLC, as Administrative Agent
		
	By:	 	 /s/ Winnalynn N. Kantaris

		 	Name: Winnalynn N. Kantaris
		 	Title:   Associate General Counsel

  
 Signature Page to Limited
Waiver and First Amendment to Credit Agreement 

 
					
	YORK CREDIT OPPORTUNITIES FUND, L.P., as Lender
		
	By:	 	 /s/ Richard P. Swanson

		 	Name:	 	Richard P. Swanson
		 	Title:	 	Chief Legal Officer
	
	YORK MULTI-STRATEGY MASTER FUND, L.P., as Lender
		
	By:	 	 /s/ Richard P. Swanson

		 	Name:	 	Richard P. Swanson
		 	Title:	 	Chief Legal Officer
	
	YORK CREDIT OPPORTUNITIES FUND, L.P., as Lender
		
	By:	 	 /s/ Richard P. Swanson

		 	Name:	 	Richard P. Swanson
		 	Title:	 	Chief Legal Officer
	
	YORK CREDIT OPPORTUNITIES INVESTMENTS FASTER FUND, L.P., as Lender
		
	By:	 	 /s/ Richard P. Swanson

		 	Name:	 	Richard P. Swanson
		 	Title:	 	Chief Legal Officer

  
 Signature Page to Limited
Waiver and First Amendment to Credit Agreement 

 
					
	YORK SELECT STRATEGY MASTER FUND, L.P., as Lender
		
	By:	 	 /s/ Richard P. Swanson

		 	Name:	 	Richard P. Swanson
		 	Title:	 	Chief Legal Officer
	
	EXUMA CAPITAL, L.P., as Lender
		
	By:	 	 /s/ Richard P. Swanson

		 	Name:	 	Richard P. Swanson
		 	Title:	 	Chief Legal Officer

  
 Signature Page to Limited
Waiver and First Amendment to Credit Agreement 

 
					
	ELLIOT ASSOCIATES, L.P., as Lender
	
	By: Elliot Capital Advisors, L.P., as General Partner
	
	By: Braxton Associates, Inc., as General Partner
		
	By:	 	 /s/ Elliot Greenberg

		 	Name:	 	Elliot Greenberg
		 	Title:	 	Vice President
	
	ELLIOT INTERNATIONAL, L.P., as Lender
	
	By: Hambledon,Inc., as General Partner
	
	By: Elliot International Capital Advisors Inc.,
	as attorney-in-fact
		
	By:	 	 /s/ Elliot Greenberg

		 	Name:	 	Elliot Greenberg
		 	Title:	 	Vice President

  
 Signature Page to Limited
Waiver and First Amendment to Credit Agreement 

 
					
	RH DEBT FUND, L.P., as Lender
	
	By: JVL Advisors, LLC, its general partner
		
	By:	 	 /s/ John V. Lovoi

		 	Name:	 	John V. Lovoi
		 	Title:	 	Manager

  
 Signature Page to Limited
Waiver and First Amendment to Credit Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]